New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (371)	1/10/2002 1:23:51 AM
From: scaram(o)uche	Read Replies (1) of 724

In discussing Fisher, I am not implying squat about a specific relationship. Both Richard and I have expressed our opinion that NBSC should by prime munch meat, and that Fisher seems like a logical muncher. However, it's pure speculation. Today's FSH presentation at H&Q...... pointed to 2002 revenues -- EXCLUDING acquisitions -- should be about $3.2 billion. Paraphrased, but perhaps a direct quote..... "provide products that reduce fear, now, unfortunately, including fear of bioterrorism." Will pursue strategic acquisitions to improve margins. There was almost continuous reference to margins and the use of acquisitions to improve them. Ex-vice pres. Gore at lunch...... referred to the need for quality epidemiology..... concerns mentioned.... anthrax, West Nile, cryptosporidium, deaths from flu, antibiotic-resistant bacteria, flu surveillance network, good vaccines. Two more indications that the company's products are in the TRUE bioterror defense sweet spot -- if one can call anything in that realm "sweet".

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next